KIF5B and lung cancer: Consistently, when the KIF5B-RET variant 1 and 2 were exogenously expressed in A549 human lung cancer cells, RET Tyr905 was phosphorylated in the absence of serum or GDNF stimulation, indicating an aberrant activation of RET kinase by fusing with KIF5B (Figure 2A).